Founded in 1999 by scientists from New England Biolabs, Cell Signaling Technology, Inc. is a global leader in developing and commercializing “smart” or activation-state-specific antibodies.  These antibodies report protein activity and play an important role in defining the cell’s major regulatory circuits and the mechanisms underlying cell function and disease.

 Cell Signaling Technology products:

Click here to find the latest Product Updates

Additional information about CST, as well as an extensive scientific reference resource for signal transduction, may be found at http://www.cellsignal.com/.